127 related articles for article (PubMed ID: 526888)
1. Silver-resistant Enterobacteriaceae from hospital patients.
Hendry AT; Stewart IO
Can J Microbiol; 1979 Aug; 25(8):915-21. PubMed ID: 526888
[TBL] [Abstract][Full Text] [Related]
2. Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine.
Gayle WE; Mayhall CG; Lamb VA; Apollo E; Haynes BW
J Trauma; 1978 May; 18(5):317-23. PubMed ID: 660684
[TBL] [Abstract][Full Text] [Related]
3. Unprecedented Silver Resistance in Clinically Isolated Enterobacteriaceae: Major Implications for Burn and Wound Management.
Finley PJ; Norton R; Austin C; Mitchell A; Zank S; Durham P
Antimicrob Agents Chemother; 2015 Aug; 59(8):4734-41. PubMed ID: 26014954
[TBL] [Abstract][Full Text] [Related]
4. Properties of silver sulfadiazine-resistant Enterobacter cloacae.
Rosenkranz HS; Coward JE; Wlodkowski TJ; Carr HS
Antimicrob Agents Chemother; 1974 Feb; 5(2):199-201. PubMed ID: 4840432
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due to Enterobacter cloacae.
Markowitz SM; Smith SM; Williams DS
J Infect Dis; 1983 Jul; 148(1):18-23. PubMed ID: 6886483
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae from six Norwegian hospitals 1991-1992.
Digranes A; Solberg CO; Sjursen H; Skovlund E; Sander J
APMIS; 1997 Nov; 105(11):854-60. PubMed ID: 9393556
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.
Bridges K; Lowbury EJ
J Clin Pathol; 1977 Feb; 30(2):160-4. PubMed ID: 321478
[TBL] [Abstract][Full Text] [Related]
8. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
Jayol A; Poirel L; Dortet L; Nordmann P
Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
[TBL] [Abstract][Full Text] [Related]
9. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
Corkill JE; Anson JJ; Hart CA
J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.
Wang JT; Wu UI; Lauderdale TL; Chen MC; Li SY; Hsu LY; Chang SC
PLoS One; 2015; 10(3):e0121668. PubMed ID: 25794144
[TBL] [Abstract][Full Text] [Related]
12. An Improved Medium for Colistin Susceptibility Testing.
Gwozdzinski K; Azarderakhsh S; Imirzalioglu C; Falgenhauer L; Chakraborty T
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514937
[TBL] [Abstract][Full Text] [Related]
13. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
14. The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia.
Fursova NK; Astashkin EI; Knyazeva AI; Kartsev NN; Leonova ES; Ershova ON; Alexandrova IA; Kurdyumova NV; Sazikina SY; Volozhantsev NV; Svetoch EA; Dyatlov IA
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():46. PubMed ID: 26526183
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
[TBL] [Abstract][Full Text] [Related]
16. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.
Munday CJ; Whitehead GM; Todd NJ; Campbell M; Hawkey PM
J Antimicrob Chemother; 2004 Sep; 54(3):628-33. PubMed ID: 15294889
[TBL] [Abstract][Full Text] [Related]
17. R factor in Enterobacter cloacae resistant to silver sulfadiazine.
Carr HS; Rosenkranz HS
Chemotherapy; 1975; 21(1):41-4. PubMed ID: 1097208
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
20. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
